[Experiences with a new percutaneously effective antirheumatic preparation].
The new substance Etofenamat (Rheumon Gel) is effective percutaneously in the treatment of rheumatic diseases. The gel is shown to be an effective antiphlogistic and analgetic, especially in vertebragenic diseases. The results of treatment of 81 patients are summarized. In a total of 56 patients, use of Etofenamat led to an evident improvement, for example, freedom from pain. Treatment for up to 9 days, eliminated pain in 73 of the 81 patients. In 28 patients out of 38, the mobility of joints was favourably effected. No side effects were observed.
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D002062:Bursitis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005439:Flufenamic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012869:Skin Absorption
D005439:Flufenamic Acid; C015207:etofenamate
Erfahrungen mit einem neuen perkutan wirksamen Antirheumatikum.